Abstract:You have accessJournal of UrologyBladder Cancer: Upper Tract TCC I1 Apr 2015MP2-02 HIGH EXPRESSION OF KARYOPHERIN α2 DEFINES POOR PROGNOSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH RADICAL NEPHROURETERECTOMY Boxing Su, Bentao Shi, Yuan Tang, Dong Fang, Genyan Xiong, Zhongqiang Guo, Xuesong Li, and Liqun Zhou Boxing SuBoxing Su More articles by this author , Bentao ShiBentao Shi More articles by this author , Yuan TangYuan Tang More articles by this author , Dong FangDong Fang More articles by this author , Genyan XiongGenyan Xiong More articles by this author , Zhongqiang GuoZhongqiang Guo More articles by this author , Xuesong LiXuesong Li More articles by this author , and Liqun ZhouLiqun Zhou More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.125AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Karyopherin α2 (KPNA2) belongs to the karyopherin (importin) family, which plays a fundamental role in nucleocytoplasmic transport. In present study, we aimed to investigate whether KPNA2 expression provides additional prognostic information in patients with upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU). METHODS The tissue microarrays (TMA) contained paired UTUC and adjacent normal tissue cores from 176 patients underwent RNU without neoadjuvant chemotherapy in our institute. The median follow-up was 36 month. The TMAs were stained immunohistochemically for KPNA2. Associations between KPNA2 expression and outcome were assessed using multivariate analysis. Strong nuclear staining >10% of nuclei was defined as high expression. KPNA2 inhibition was performed by siRNA technologies in vitro, and its effect on cellular viability, migration and apoptosis were evaluated. KPNA2 expression in normal and carcinoma urothelial cell lines was evaluated by western blot analysis. RESULTS KPNA2 expression is significantly higher in UTUC than in adjacent normal tissues. High KPNA2 immunoreactivity was identified as a novel independent predictor for subsequent bladder recurrence (hazard ratio [HR]: 2.017, 95% CI 1.13-3.61, p=0.018). The five-year recurrence-free survival rate for KPNA2-low expression patients (71.9%) was significantly higher than that for KPNA2-high expression patients (59.4%) (p = 0.047). Similarly, high KPNA2 expression was demonstrated to be an independent predictor of poor disease free survival (DFS, HR: 2.754, 95% CI 1.68-4.51, p=0.001) and overall survival (OS, HR: 4.480, 95% CI 1.84-10.89, p=0.001) in patients with UTUC after RNU in multivariate analysis. Further, in vitro experiments showed KPNA2 expression was higher in carcinoma than in normal urothelial cell lines. KPNA2 knockdown resulted in decreased cell viability and migration as well as increased apoptosis in urothelial carcinoma cell lines. KPNA2 knockdown induced PARP cleavage as a marker of apoptosis. This study is limited by its retrospective and single-institution study design as well as relatively short follow-up duration. CONCLUSIONS KPNA2 is a novel independent prognostic marker for bladder recurrence, DFS and OS of patients with UTUC receiving RNU. Introducing KPNA2 immunohistochemistry in routine diagnostics of UTUC may help to identify patients who need more aggressive treatment regimens. Moreover, KPNA2 could be a promising therapeutic target in molecular medicine. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e10-e11 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Boxing Su More articles by this author Bentao Shi More articles by this author Yuan Tang More articles by this author Dong Fang More articles by this author Genyan Xiong More articles by this author Zhongqiang Guo More articles by this author Xuesong Li More articles by this author Liqun Zhou More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Aberrant Expression Of Kpna2 Is Associated With A Poor Prognosis And Contributes To Oct4 Nuclear Transportation In Bladder Cancer

Overexpression of the ASPM Gene is Associated with Aggressiveness and Poor Outcome in Bladder Cancer.

KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy

Effect of KPNA2 gene silence and overexpression on proliferation of human bladder cancer cell lines 5637

Heterogeneous Nuclear Ribonucleoprotein K is Associated with Poor Prognosis and Regulates Proliferation and Apoptosis in Bladder Cancer

Upregulated KPNA2 Promotes Hepatocellular Carcinoma Progression and Indicates Prognostic Significance Across Human Cancer Types

Increased Nuclear Transporter KPNA2 Contributes to Tumor Immune Evasion by Enhancing PD-L1 Expression in PDAC

The Predictive Value of PFKFB3 in Bladder Cancer Prognosis

KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis

E2F1 and E2F7 Differentially Regulate KPNA2 to Promote the Development of Gallbladder Cancer.

Increased Expression of Long Non-Coding RNA CCEPR is Associated with Poor Prognosis and Promotes Tumorigenesis in Urothelial Bladder Carcinoma

MP2-02 HIGH EXPRESSION OF KARYOPHERIN α2 DEFINES POOR PROGNOSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH RADICAL NEPHROURETERECTOMY

Long Noncoding RNA Expression Signatures of Bladder Cancer Revealed by Microarray

Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3

Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma

Abstract 7269: Karyopherin α-2, a nuclear export protein, promotes cancer progression in lung adenocarcinoma

Comprehensive analysis of karyopherin alpha family expression in lung adenocarcinoma: Association with prognostic value and immune homeostasis

KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma

MALAT-1 and ncRAN, show marked potential in the field of bladder cancer progression (8‐10). However, the genome‐wide expression and functional significance of lncRNAs in bladder cancer

Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p